How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
The frontier model is a commodity. The companies winning are the ones that own distribution, and venture capital is paying up ...
Everyone is racing to point powerful AI models at drug discovery. A growing camp argues the real prize is the layer beneath the models — the connected biological knowledge they reason over — and that ...
Building a model capable of RSI would require automating a range of specialist tasks currently carried out by humans. At present data scientists work on the theory of AI and coders put it into ...
Educational P-Code Virtual Machine and Debugger plugin for IntelliJ IDEA. P-Code VM helps students learn compiler construction, intermediate code generation, stack machines, recursion, frames, and ...
Thanks for attending the 2026 Bank of America Healthcare Conference. My name is Alec Stranahan. I cover Recursion and SMid Biotech at Bank of America. And I'm pleased to be joined today by Ben Taylor, ...
Even as leading AI providers like OpenAI and Anthropic battle over the compute to train and release ever larger, more powerful models, other labs are going in a different direction — pursuing the ...
Detailed price information for Recursion Pharmaceuticals Inc Cl A (RXRX-Q) from The Globe and Mail including charting and trades.
SALT LAKE CITY, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX) a leading clinical stage TechBio company decoding biology to radically improve lives, today reported business updates and ...
Abstract: Return-oriented programming (ROP) attacks pose a significant threat to the control-flow integrity (CFI) of Internet of Things (IoT) devices, which operate in resource-constrained ...
After twelve years at the helm of AI-drug developer Recursion, Chris Gibson will hand the CEO baton to Najat Khan, PhD, the company’s chief R&D officer and chief commercial officer, effective January ...